Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
D 29.28 0.72% 0.21
CNCR closed down 0.65 percent on Wednesday, May 12, 2021, on 2.02 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CNCR trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.72%
Inside Day Range Contraction 0.72%
180 Bearish Setup Bearish Swing Setup 0.17%
Volume Surge Other 0.17%
200 DMA Resistance Bearish -2.04%
20 DMA Resistance Bearish -2.04%
Morning Star Bullish -2.04%
Multiple of Ten Bearish Other -2.04%
MACD Bearish Centerline Cross Bearish 0.24%
MACD Bearish Signal Line Cross Bearish 0.24%
Older End-of-Day Signals for CNCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 42 minutes ago
Rose Above Previous Day's High about 2 hours ago
1.5x Volume Pace about 2 hours ago
Up 1% about 2 hours ago
2x Volume Pace about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Loncar Cancer Immunotherapy ETF Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.


Classification

Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Cancer SPDR Betashares Immune System Immunotherapy Cancer Immunotherapy Technology Sector Technology Sectors Lonca Biotechnology Sectors Loncar Cancer Immunotherapy Index

Top 10 Components

Symbol Grade Price % Change Allocation
IMAB A 0.27 5.79
MGNX C -3.21 5.19
BGNE C -0.59 5.04
BNTX B -3.45 5.03
NKTR F -0.11 4.14
RCUS D -5.28 4.08
GILD A 1.22 4.01
LEGN A 0.69 3.98
ALLO F -4.11 3.97
BMY A 0.96 3.93
View All CNCR Holdings

Is CNCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.818
52 Week Low 23.99
Average Volume 6,364
200-Day Moving Average 29.95
50-Day Moving Average 30.10
20-Day Moving Average 30.01
10-Day Moving Average 29.85
Average True Range 0.74
ADX 18.39
+DI 21.34
-DI 35.44
Chandelier Exit (Long, 3 ATRs ) 29.13
Chandelier Exit (Short, 3 ATRs ) 30.17
Upper Bollinger Band 31.64
Lower Bollinger Band 28.37
Percent B (%b) 0.21
BandWidth 10.89
MACD Line -0.22
MACD Signal Line -0.10
MACD Histogram -0.1195
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.78
Resistance 3 (R3) 29.80 29.59 29.66
Resistance 2 (R2) 29.59 29.41 29.58 29.62
Resistance 1 (R1) 29.33 29.30 29.23 29.31 29.58
Pivot Point 29.12 29.12 29.07 29.11 29.12
Support 1 (S1) 28.86 28.94 28.76 28.84 28.56
Support 2 (S2) 28.65 28.83 28.64 28.52
Support 3 (S3) 28.39 28.65 28.48
Support 4 (S4) 28.37